INS and type 2 diabetes mellitus: The same integrated personalised diabetes management program was analyzed in a one-arm study with American T1D and T2D patients who are treated with insulin and showed the same average reductions after 6 months of 0.5% ± 0.6% (p = 0.045, d = 0.81) for patients in specialist care settings (26).